Concerted changes in transcripts in the prefrontal cortex precede neuropathology in Alzheimer's disease
The DOI matches its Crossref record; 92 of the 93 references it cites were found in a registry or an index.
Abstract
Using the Braak staging for neurofibrillary changes as an objective indicator of the progression of Alzheimer's disease, we have performed a systematic search for global gene expression changes in the prefrontal cortex during the course of Alzheimer's disease. In the prefrontal cortex, senile plaques and neurofibrillary changes start to appear around Braak stage III, allowing for the detection of changes in gene expression before, during and after the onset of Alzheimer's disease neuropathology. Two distinct patterns of tightly co-regulated groups of genes were observed: (i) an increase in expression in early Braak stages, followed by a decline in expression in later stages (the UPDOWN clusters; containing 865 genes) and (ii) a decrease in expression in early Braak stages, followed by an increase in expression in later stages (the DOWNUP clusters; containing 983 genes). The most profound changes in gene expression were detected between Braak stages II and III, just before or at the onset of plaque pathology and neurofibrillary changes in the prefrontal cortex. We also observed an increase in intracellular beta amyloid staining from Braak stages I to III and a clear decrease in Braak stages IV to VI. These data suggest a link between specific gene expression clusters and Alzheimer's disease-associated neuropathology in the prefrontal cortex. Gene ontology over-representation and functional gene network analyses indicate an increase in synaptic activity and changes in plasticity during the very early pre-symptomatic stage of the disease. In later Braak stages, the decreased expression of these genes suggests a reduction in synaptic activity that coincides with the appearance of plaque pathology and neurofibrillary changes and the clinical diagnosis of mild cognitive impairment. The interaction of the ApoE genotype with the expression levels of the genes in the UPDOWN and DOWNUP clusters demonstrates that the accelerating role of ApoE-ε4 in the progression of Alzheimer's disease is reflected in the temporal changes in gene expression presented here. Since the UPDOWN cluster contains several genes involved in amyloid precursor protein processing and beta amyloid clearance that increase in expression in parallel with increased intracellular beta amyloid load, just before the onset of plaque pathology in the prefrontal cortex, we hypothesize that the temporally orchestrated increase in genes involved in synaptic activity represents a coping mechanism against increased soluble beta amyloid levels. As these gene expression changes occur before the appearance of Alzheimer's disease-associated neuropathology, they provide an excellent starting point for the identification of new targets for the development of therapeutic strategies aimed at the prevention of Alzheimer's disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early transcriptomic studies utilizing microarrays revealed alterations in synaptic, immune, and metabolic pathways that appear even before clinical symptoms, underscoring the potential for pre-symptomatic intervention120,125,161.”
From Artificial intelligence-driven multi-omics approaches in Alzheimer's disease: Progress, challenges, and future directions (2025) · cites this paper as [125]
In the citing paper
“and the decreased expression of these synaptic genes in later Braak stages, suggesting a reduction in synaptic activity that coincides with AD neuropathology and cognitive impairment 252.”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [252]
In the citing paper
“Systematic search for global gene expression changes in PFC during the course of AD has found a temporally orchestrated increase of genes involved in synaptic activity during the very early pre-symptomatic stage, probably representing a coping mechanism against increased β-amyloid levels, and the decreased expression of these synaptic genes in later Braak stages, suggesting a reduction in synaptic”
From Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications (2022) · cites this paper as [252]
In the citing paper
“Several studies have shown altered gene expression in the post‐mortem brain of cases with AD and related animal models 7, 67, 99.”
From Altered Machinery of Protein Synthesis in Alzheimer's: From the Nucleolus to the Ribosome (2016) · cites this paper as [7]
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 3×
“We selected the prefrontal cortex (PFC), because it is affected relatively late in the Alzheimer’s disease process (Braak and Braak, 1991).”
BackgroundMethodTriple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J., Guillozet-Bongaarts, A., Ohno, M., Disterhoft, J., Van Eldik, L., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.1202-06.2006 · Cited by 3,530 · cited 1×
“, 2002), and in several transgenic mouse models for Alzheimer’s disease (Oakley et al., 2006; Oddo et al., 2006).”
BackgroundHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326 · cited 2×
“In addition to ApoE, variations in CLU, PICALM and CR1 have recently been associated with sporadic Alzheimer’s disease (Harold et al., 2009; Lambert et al., 2009).”
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · cited 1×
“Alzheimer’s disease disease progression can be monitored by the presence of tangle-bearing neurons in well-defined brain areas, and is classified into 6 Braak stages (Braak I-VI) (Braak and Braak, 1991; Braak et al., 2006).”
BackgroundGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Improved scoring of functional groups from gene expression data by decorrelating GO graph structure
Alexa, A., Rahnenführer, J., & Lengauer, T. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btl140 · Cited by 2,188
Intracellular amyloid-β in Alzheimer's disease
LaFerla, F. M., Green, K. N., & Oddo, S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2168 · Cited by 1,942
Gene regulation and DNA damage in the ageing human brain
Lu, T., Pan, Y., Kao, S.-Y., Li, C., Kohane, I., Chan, J., & Yankner, B. A. (2004) · Nature · doi:10.1038/nature02661 · Cited by 1,874
Cited by
Items 201–251 of 251
Ataellahi, F., Masoudi, R., & Haddadi, M. (2022) · Molecular Biology Reports · doi:10.1007/s11033-022-08059-9 · Cited by 4
Chen, J., Han, Z., Wang, Z., Chen, L., Wang, S., Yao, W., & Xue, Z. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06148-6 · Cited by 3
Jorge, N. A. N., Ueberham, U., Knobloch, M., Stadler, P. F., Fallmann, J., & Arendt, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-99760-5 · Cited by 3
Majumder, A., & Sarkar, M. (2014) · International Journal of Computer Theory and Engineering · doi:10.7763/ijcte.2014.v6.895 · Cited by 3
Carrillo, P., Rey, R., Padovan, C., Herrmann, M., & Dorey, J. (2022) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000627 · Cited by 3
Li, W., Zhang, Q., Qu, K., & Long, Q. (2024) · Statistics in Biosciences · doi:10.1007/s12561-024-09452-7 · Cited by 3
Cholinergic synaptic plasticity shapes resilience and vulnerability to tauPreprint
Onuska, K. M., Shanks, H. R. C., Devito, L. A., Qi, Q., Crooks, A. M., Germán-Castelán, L., Ngo, G. N., Haast, R. A. M., Andrews, T. S., Williams, K. M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.27.656174 · Cited by 3
The effect of early growth response 1 on levels of Amyloid‐β 40 peptide in U87MG cells
Zhao, X., Wang, X., Su, G., Sun, Q., Fu, J., Zhang, H., & Teng, J. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27627 · Cited by 2
The use of biomarkers in non-demented AD patients for clinical trial design and clinical practice
Bertens, D. (2021) · Pure Amsterdam UMC · Cited by 2
Ishunina, T. A., & Swaab, D. F. (2021) · PubMed · Cited by 2
Self-citationDatta, D., Wang, M., & Arnsten, A. F. T. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1750092 · Cited by 1
Shah, K. C., Littlestone, E. D., Ahmmad, M. R., Wang, C., Xu, Y., & Zhang, X. (2026) · Biomedicines · doi:10.3390/biomedicines14092032 · Cited by 1
Girard, S. D. (2012) · theses.fr (ABES) · doi:10.70675/94b339faz7b8ez4cdbz9f04z337c95c8f7db · Cited by 1
Montaser, A. (2023) · UEF eRepo (University of Eastern Finland) · Cited by 1
Princy, S. B., Jacob, M., Sarala, G., Rajanaryanan, S., Kannan, S., Naveenkumar, R., & Deepender (2026) · Genetics and Molecular Research · doi:10.4238/trjq2j23 · Cited by 1
Visser, P. J., Reus, L. M., Gobom, J., Jansen, I. E., Dicks, E., van der Lee, S. J., Tsolaki, M., Verhey, F. R. J., Popp, J., Martínez‐Lage, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19445890
Drug Delivery to the Central Nervous System Using Drug Nanocrystals
Tao, Y., Fuster, M. G., Sangalli, M. E., & Paredes, A. J. (2026) · Springer eBooks · doi:10.1007/978-3-032-10238-6_7
Visser, P. J., Reus, L. M., Gobom, J., Jansen, I. E., Dicks, E., van der Lee, S. J., Tsolaki, M., Verhey, F. R. J., Popp, J., Martinez-Lage, P., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19445893
Bockaert, J. (2012) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717967959.793467616
Neuronal CD2AP Promotes Hyperphosphorylated Tau Accumulation and Propagation in Early AlzheimerPreprint
Zhu, Q., Zhang, Y., Guo, L.-Y., Fortes, J. M., Hu, Y., Balesar, R. A., Swaab, D. F., & Bao, A. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5270410
Self-citationLeandro, G. D. S. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2017.tde-04012017-141718
Rodent models of Alzheimer’s disease
Kasza, Á. (2018) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.9743
Prefrontal gene expression changes in mood disorders and suicide
Zhao, J. (2018) · Data Archiving and Networked Services (DANS)
Xiang, S., Johnson, T. S., Dong, T., Huang, Z., Cheng, M., Wang, T., Yang, K., Ni, D., Huang, K., & Zhang, J. (2020) · Research Square · doi:10.21203/rs.3.rs-26385/v1
Johnson, T. S., Xiang, S., Dong, T., Huang, Z., Cheng, M., Wang, T., Yang, K., Ni, D., Huang, K., & Zhang, J. (2020) · Research Square · doi:10.21203/rs.3.rs-26385/v2
Johnson, T. S., Xiang, S., Dong, T., Huang, Z., Cheng, M., Wang, T., Yang, K., Ni, D., Huang, K., & Zhang, J. (2020) · doi:10.21203/rs.3.rs-92026/v1
Novel extensions of label propagation for biomarker discovery in genomic data
Stokes, M. E. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
The role of autophagy in Alzheimer disease
Jaeger, P. A. (2011) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-8320
Alzheimer’s Disease Genomics and Clinical Applications
Lee, T.-S. W., & Sian, M. (2011) · InTech eBooks · doi:10.5772/18773
The Possible Role of Kallikrein-6, 7, and Potassium Channels Proteins in Alzheimer’s Disease
Bulduk, E. B., Yıldırım, F., & Yıldırım, Z. (2021) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2021.50374
Park, E., Jeon, E. H., Kim, I.-H., & Park, S. (2010) · Genomics & Informatics · doi:10.5808/gi.2010.8.4.185
Qi, X.-H., Chen, P., Wang, Y.-J., Zhou, Z., Liu, X.-C., Fang, H., Wang, C.-W., Liu, J., Liu, R.-Y., Liu, H.-K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24966058
Qi, X.-H., Chen, P., Wang, Y.-J., Zhou, Z., Liu, X.-C., Fang, H., Wang, C.-W., Liu, J., Liu, R.-Y., Liu, H.-K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26665039
Qi, X.-H., Chen, P., Wang, Y.-J., Zhou, Z., Liu, X.-C., Fang, H., Wang, C.-W., Liu, J., Liu, R.-Y., Liu, H.-K., et al. (2024) · Figshare · doi:10.6084/m9.figshare.24965934
Multiomic and functional characterization of Alzheimer's disease-associated early targets
Marttinen, M. (2018) · UEF eRepo (University of Eastern Finland)
Parra‐Damas, A., Molecular, U. A. D. B. D. D. B. I. D. B., & de Neurociències, U. A. D. B. I. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Glial cells and neuronal function in Alzheimer's disease
Smit, T. (2020) · UvA-DARE (University of Amsterdam)
Cabré, C. B. (2024) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Rauskolb, S., Andreska, T., Fries, S., von Collenberg, C. R., Blum, R., Monoranu, C.-M., Villmann, C., & Sendtner, M. (2022) · Figshare · doi:10.6084/m9.figshare.19720097
Régulation de la métalloprotéase ADAM10 par les tétraspanines
Ottavi, J. (2013) · theses.fr (ABES) · doi:10.70675/a4ae1eb7ze0b5z4c18z8fa2z198a029815db
Potemkin, N. (2021) · Otago University Research Archive (University of Otago)
Kramer, M. (2022) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · doi:10.13154/294-8941
Großer, C. (2016) · DuEPublico (University of Duisburg-Essen)
Fontana, R. (2016) · Padua@research (University of Padova)
Stress and memory in health and disease: Impact on Alzheimer's disease and memory mechanisms
Lesuis, S. L. (2019) · UvA-DARE (University of Amsterdam)
Mahady, L. J. (2018) · Arizona State University Library Digital Repository (Arizona State University)
Epigenetic Mechanisms in Neurodegenerative Disease
Vadnal, J. (2012) · OhioLink ETD Center (Ohio Library and Information Network)
Cullen, D. R. (2016) · eSpace (Curtin University)
Metadata
- Authors
- Bossers, K., Wirz, K. T. S., Meerhoff, G. F., Essing, A. H. W., van Dongen, J. W., Houba, P., Kruse, C. G., Verhaagen, J., & Swaab, D. F.
- Affiliations
- Netherlands Institute for Neuroscience (NL)
- Abbott (Netherlands) (NL)
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10-01
- Volume
- 133
- Issue
- 12
- Pages
- 3699-3723
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2084210522
- Cited by
- 230
- References
- 93
- Citations by year
- 2026: 4 · 2025: 5 · 2024: 16 · 2023: 13 · 2022: 18 · 2021: 21 · 2020: 12 · 2019: 15 · 2018: 13 · 2017: 16 · 2016: 13 · 2015: 16 · 2014: 17 · 2013: 23 · 2012: 18
- FWCI
- 10.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain (publishedVersion)
- PubMed (publishedVersion)
- KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Funders
- Top Institute Pharma (T5-207)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- prefrontal cortex, gene expression changes, Braak staging, neurofibrillary tangles, amyloid plaques, amyloid-beta, synaptic activity, synaptic plasticity, APOE ε4, APP processing, mild cognitive impairment, presymptomatic stage
- MeSH terms
- Aged, Aging, Alzheimer Disease, Apolipoproteins E, Female, Multigene Family, Humans, Immunohistochemistry, Male, Synaptic Transmission, Nucleic Acid Hybridization, RNA, Transcription, Genetic, Blotting, Western, Gene Expression, Amyloid beta-Peptides, Prefrontal Cortex, Disease Progression, Reverse Transcriptase Polymerase Chain Reaction, Sirtuins, Microarray Analysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.